|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/496 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07D 471/04 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3890740 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19831677.0 |
| Date of filing the European patent application | 2019-12-18 | |
| (97) | Date of publication of the European application | 2021-10-13 |
| (45) | Date of publication and mention of the grant of the patent | 2023-03-01 |
| (46) | Date of publication of the claims translation | 2023-03-27 |
| (86) | Number | PCT/EP2019/085982 |
| Date | 2019-12-18 |
| (87) | Number | WO 2020/127503 |
| Date | 2020-06-25 |
| (30) | Number | Date | Country code |
| 201820582 | 2018-12-18 | GB | |
| 201911007 | 2019-08-01 | GB | |
| 201917701 | 2019-12-04 | GB |
| (72) |
DE HAARD, Hans , BE
FUNG, Samson , BE
LEUPIN, Nicolas , BE
VAN ROMPAEY, Luc , BE
OCHSENBEIN, Adrian , CH
RIETHER, Carsten , CH
|
| (73) |
Argenx BVBA ,
Industriepark Zwijnaarde 7, 9052 Gent,
BE
University of Bern , Verwaltungsdirektion Hochschulstrasse 6, 3012 Bern, CH |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | CD70 ir BCL-2 inhibitoriaus venetoklakso kompleksinė terapija, skirta ūminės mieloidinės leukemijos gydymui |
| CD70 AND VENETOCLAX, A BCL-2 INHIBITOR, COMBINATION THERAPY FOR TREATING ACUTE MYELOID LEUKEMIA |
| Payment date | Validity (years) | Amount | |
| 2025-12-02 | 7 | 162.00 EUR |
| 2026-12-18 |